文献速递腹部技术与安全US

人工智能辅助操作者在超声检查中实时检测局灶性肝脏病变:一项随机对照研究

Artificial intelligence assists operators in real-time detection of focal liver lesions during ultrasound: A randomized controlled study.
PubMed 文献 · Eur J Radiol · 2023-06-20

这项单中心前瞻性随机对照研究评估人工智能系统能否在超声检查中实时辅助非专家和专家操作者检测局灶性肝脏病变。非专家操作者中,AI辅助组病变检出率显著高于无AI辅助组(36.9% vs 21.4%,p<0.001);专家操作者中两组检出率无显著差异(66.7% vs 63.3%,p=0.32)。两组假阳性率在非专家(14.2% vs 9.2%,p=0.08)和专家(8.6% vs 9.0%,p=0.85)中均无显著差异。

要点

  • 非专家操作者使用AI辅助后局灶性肝脏病变检出率由21.4%提高至36.9%(p<0.001)。
  • 专家操作者有无AI辅助的病变检出率无显著差异(66.7% vs 63.3%,p=0.32)。
  • 非专家和专家操作者中,AI辅助与否的假阳性率均无显著差异。

核心结论

  • AI系统可显著提高非专家操作者在超声检查中对局灶性肝脏病变的检出率,研究结果可能支持未来在由非专家操作者进行超声检查的资源有限环境中使用该AI系统。

研究设计与样本

  • 单中心前瞻性随机对照研究,非专家操作者组纳入260例患者共271个局灶性肝脏病变,专家操作者组纳入244例患者共240个局灶性肝脏病变,患者分别在有和无AI辅助下接受两次超声检查,采用McNemar检验比较配对病变检出率和假阳性率。

诊断标准与关键数值

  • 非专家操作者组局灶性肝脏病变检出率:AI辅助组36.9% vs 无AI辅助组21.4%,p<0.001。
  • 专家操作者组局灶性肝脏病变检出率:AI辅助组66.7% vs 无AI辅助组63.3%,p=0.32。
  • 非专家操作者组假阳性检出率:AI辅助组14.2% vs 无AI辅助组9.2%,p=0.08。
  • 专家操作者组假阳性检出率:AI辅助组8.6% vs 无AI辅助组9.0%,p=0.85。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Detection of hepatocellular carcinoma (HCC) is crucial during surveillance by ultrasound. We previously developed an artificial intelligence (AI) system based on convolutional neural network for detection of focal liver lesions (FLLs) in ultrasound. The primary aim of this study was to evaluate whether the AI system can assist non-expert operators to detect FLLs in real-time, during ultrasound examinations.

METHOD: This single-center prospective randomized controlled study evaluated the AI system in assisting non-expert and expert operators. Patients with and without FLLs were enrolled and had ultrasound performed twice, with and without AI assistance. McNemar's test was used to compare paired FLL detection rates and false positives between groups with and without AI assistance.

RESULTS: 260 patients with 271 FLLs and 244 patients with 240 FLLs were enrolled into the groups of non-expert and expert operators, respectively. In non-experts, FLL detection rate in the AI assistance group was significantly higher than the no AI assistance group (36.9 % vs 21.4 %, p < 0.001). In experts, FLL detection rates were not significantly different between the groups with and without AI assistance (66.7 % vs 63.3 %, p = 0.32). False positive detection rates in the groups with and without AI assistance were not significantly different in both non-experts (14.2 % vs 9.2 %, p = 0.08) and experts (8.6 % vs 9.0 %, p = 0.85).

CONCLUSIONS: The AI system resulted in significant increase in detection of FLLs during ultrasound examinations by non-experts. Our findings may support future use of the AI system in resource-limited settings where ultrasound examinations are performed by non-experts. The study protocol was registered under the Thai Clinical Trial Registry (TCTR20201230003), which is part of the WHO ICTRP Registry Network. The registry can be accessed via the following URL: https://trialsearch.who.int/Trial2.aspx?TrialID=TCTR20201230003.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Tiyarattanachai, Apiparakoon, Chaichuen, et al. Artificial intelligence assists operators in real-time detection of focal liver lesions during ultrasound: A randomized controlled study. Eur J Radiol. 2023. PMID: 37390663. doi:10.1016/j.ejrad.2023.110932

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。